SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000792977-19-000121
Filing Date
2019-08-07
Accepted
2019-08-07 17:26:16
Documents
106
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amag6301910-q.htm   iXBRL 10-Q 2197001
2 EXHIBIT 31.1 ex3112q19.htm EX-31.1 16297
3 EXHIBIT 31.2 ex3122q19.htm EX-31.2 16058
4 EXHIBIT 32.1 ex3212q19.htm EX-32.1 8297
5 EXHIBIT 32.2 ex3222q19.htm EX-32.2 8418
11 amag_rgba03.jpg GRAPHIC 41954
  Complete submission text file 0000792977-19-000121.txt   11034027

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amag-20190630.xsd EX-101.SCH 77327
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amag-20190630_cal.xml EX-101.CAL 147024
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amag-20190630_def.xml EX-101.DEF 375237
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amag-20190630_lab.xml EX-101.LAB 929394
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amag-20190630_pre.xml EX-101.PRE 570038
12 EXTRACTED XBRL INSTANCE DOCUMENT amag6301910-q_htm.xml XML 2122425
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10865 | Film No.: 191006530
SIC: 2834 Pharmaceutical Preparations